chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection site reaction diagnosed by doctor visit on 8-18-12 & told to treat with cold compress & BENADRYL.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 18Dec2020 as dose 1, single (Lot number: EKS730), on 08Jan2021 as dose 2, single (Lot number: ELIZ84) and on 24Sep2021 as dose 3 (booster), single (Lot number: FF2580) at the age of 65 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 31Mar2022 at 14:30 as dose 4 (booster), single (Lot number: 046L21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Mild asthma" (unspecified if ongoing), notes: Mild asthma; "hypertension" (unspecified if ongoing); "psoriasis" (unspecified if ongoing); "hyperlidemia" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Proton pump inhibitors, reaction(s): "Known allergies: Proton pump inhibitors", notes: Known allergies: Proton pump inhibitors; Biaxin, reaction(s): "Known allergies: Biaxin", notes: Known allergies: Biaxin. Patient received treatment with Paxlovid from 17Jun2022 to 22Jun2022.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events Vaccination failure and "covid-19"  and the suspect drug BNT162b2.
Patient reported within 30-45mins of vaccination that she noticed tingling/numbing sensation that was presented from site of injections down to her fingers on her right arm. She described it as "her arm filled asleep". No other symptoms reported. Nurse on staff recommended her to take some ibuprofen and cold compress for 20 mins.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 22-AUG-2007, the patient was inoculated with ZOSTAVAX at a heart center as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 14-FEB-2015, the patient was treated at a heart center for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
2 days after 1st dose: severe headache and body aches. Severe tinnitus. Insomnia, constipation. After 3 days tingling numbness and weekends in extremities. Loss of appetite. Weight loss. Symptoms persisting for 3 weeks.
headache; muscle pain; chills; fever; injection site redness and swelling; injection site redness and swelling; Injections site pain; tiredness; This is a spontaneous report from a contactable nurse (patient herself). A 54-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EK5730), via intramuscular on 05Jan2021 10:30 in left arm at single dose for covid-19 immunization.  Medical history included hypothyroidism, arthritis, hypertension, eczema. Prior to vaccination, the patient was diagnosed with COVID-19. The patient was known allergies: daptomycin and cefdinir (OMNICEF). The most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination included clonidine, levothyroxine sodium (SYNTHYROID), ibuprofen. The patient experienced injections site pain, tiredness, headache, muscle pain, chills, fever, injection site redness and swelling on 06Jan2021 11:00 with outcome of recovering.  Since the vaccination, the patient had not been tested for COVID-19. No treatment received for the adverse event. Events were reported as non-serious.
Chronic Pain - Knees, feet, lumbar region, cervical region, trapezius region, occipital region Brain fog Chronic Inflammation  Fatique P.E.M.
Monovalent dose was administered as #1 of series on 4/19/23 when Monovalent was no longer approved as any use on 4/18/23. Pharmacy staff have not received any complaints from patient about adverse events. Was notified by DOH of this error. 3 Attempts to contact patient to notify of this error. Had to leave voice message. Have not heard back from the patient yet.
1st day post experienced generalized achiness, no temperature, no family members ill, developed diarrhea x 3 days, when reported (10-20) states has "beginnings of a cold".  All other symptoms have resolved.
Patient notified clinic with concerns of increased blood pressure, numbness, and tightness to left arm after vaccination , dizziness, and headache.
Heard through a family member had some feeling badly and some respiratory symptoms. We do not have any real information. This is a coroners case.
Pt recvd 2nd dose Hep B vax & devel dizziness which persisted x 30 hrs & then resolved;
Began with minor soreness in shoulder at injection site. Pain increased to moderate severity into the evening.  In morning more generalized muscle aches, moderate.  By afternoon, felt like minor flu. At 5 pm took temp, 100.5.  Now continues into evening.
I had swollen eyes and face; I had swollen eyes and face; Itching/I had swollen eyes and face and I had some rash and got itching; Rash/had swollen eyes and face and I had some rash; Left side of my face is worse than my right side; When I touch my face it looks like my left side has fever but it is just hard; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown), dose 1 via an unspecified route of administration on 02Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient experienced left side of my face was worse than my right side; when I touch my face it looks like my left side has fever but it was just hard on 03Mar2021. Patient stated, I got my first vaccine on Tuesday, 02Mar and the first day I had no problem. Next day my face start having some rash (03Mar2021). Left side of my face was worse than my right side (03Mar2021). Day after that I had swollen eyes and face and I had some rash and got itching (04Mar2021). I was not sure it was vaccine or what, but Saturday and Sunday I was bad. Patient wanted to know was this normal, should I do anything or should I go the doctor today. Today I was better than yesterday, but my face was so hard. When I touch my face, it looks like my left side had fever, but it was just hard. The clinical outcome of the events was unknown.  No follow-up attempts are Possible. information about lot/batch number cannot be obtained.
This spontaneous report as received from a practice manager refers to a multiple patients of unknown age. On unknown dates, the patients were vaccinated with improperly store doses of RECOMBIVAX HB for prophylaxis. No adverse effects reported. The temperature and time involved were not reported.
Mother phoned on 7/26/05 to report child never ran fever or complained.  Slight redness over right deltoid Friday AM (7/22/05.  Saturday morning had swelling over entire deltoid with redness and itching.  Child never complained.  Father insisted child go to MD - was seen on Saturday, 7/23/05. Per Mother, child right arm was improving by Saturday afternoon.
Information has been received from a health professional at a physician's office, a physician and two company representatives concerning a 54 year old male patient. The patient was vaccinated with .65 ml ZOSTAVAX on 05-JUN-2012 (also reported as 25-JUN-2012). No other co-suspects were reported. No concomitant medications were reported. It was reported 5 days after getting the vaccine, the patient called the doctor's office because he had experienced a fever and a sore throat and requested an antibiotic, which the physician did not prescribe. It was reported the patient was very sick for three weeks after getting the vaccine. The physician reported "this patient may have to have his tonsils out". Treatment included over the counter medications (not specified). The outcome of sore throat and fever was reported as recovering/resolving. Additional information has been requested.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. There were no pertinent medical history and concurrent conditions reported. On an unknown date an unspecified number of patients were vaccinated with ROTATEQ (dose, frequency, lot#, expiry date and indication were not reported), which was stored improperly for a period of 25 days. No adverse effect was reported. It was unspecified if the patient sought medical attention. It was reported that unknown number of patients were also administered ROTATEQ that had been involved in the previously AE due to improper storage for 25 days. It was recently discovered that the ROTATEQ has been stored in the same refrigerator with RECOMBIVAX23 during low temperature excursion. This report is one of four linked reports from the same reporter. Additional information has been requested.
she started to feel nauseated and dizzy and faint. she said she really hates needles and has passed out  from getting blood drawn in the past. she feels like this situation was anxiety. she sat in a reclining chair at our Clinic for awhile and felt better.
Chest tightness, shortness of breath, and muscle tightness, given 25mg of BENADRYL and 2 liters of oxygen and taken to emergency room.
Severe pain right upper arm/shoulder spreading around area of injection. Difficulty lifting arm and moving arm certain directions. Tingling skin on forearm/hand. Worsening as time goes by. Scheduled an orthopedic appointment for Monday 12/15/2014.
Information has been received from a physician and health professional concerning a 13 week old male, with no medical history and no allergies, who on 29-NOV-2006 was vaccinated with a first 2 ml oral dose of Rotateq (Lot# 655484/1032F). Concomitant vaccines administered on the same day included Ipol, Comvax, Prevnar and DTaP. The patient developed diarrhea on an unknown date and was seen in the emergency room. The patient was not hospitalized. At 3 months of age, on 03-JAN-2007, the patient tested positive for rotavirus. The reporter was not sure which rotavirus test was performed. The reporter did not have any additional information at the time of the report. The patient's rotavirus was considered to be an other important medical event (OMIC) by the reporter. Additional information has been requested.
Client is a 10 year old female who came in for her second dose appointment. Client's appointment date was 12/8/21 but mistakenly came in today. Client's first dose was on 11/15/21. Client received her second dose today 12/1/21. Client's mother was notified of the error and educated on the need to revaccinate the client 21 days or later from the erroneously given dose. Mother acknowledged the instructions and stated that she would plan on revaccinating 21 days from now or later.
The patient experienced syncope shortly after receiving the vaccine.  She was sweaty, pale, and unresponsive for several minutes.
Patient complaints include, cold/chills, injection site soreness, and 103F fever. Patient was instructed to use TYLENOL to lower fever- if fever still persists and progress, seek emergency help.
taste issue; smell issue; This case was reported by a consumer via interactive digital media and described the occurrence of taste disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced taste disorder and parosmia. On an unknown date, the outcome of the taste disorder and parosmia were unknown.   It was unknown if the reporter considered the taste disorder and parosmia to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Shingles vaccine and believed that, it injured the patient as he/she could not stand the smell of many things or taste many foods he/she once loved. The case is linked with the case US2021AMR203502, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR203502:same patient, different event
Severe weakness, fatigue, nausea resulting in a faint. I was overcome with feeling very ill the day after I got my booster, felt very weak and nauseous, and then fainted suddenly on the morning of 1/14. I have never had a syncopal episode before.  I am currently also suffering from severely chapped, burning lips since getting the booster shot.
After receiving the H1N1 vaccine on 1/9/10 excessive amounts of hair began to fall out of patient's head on 1/10/10.  This has continued for four weeks and the affected area has a fist size amount of hair loss (left rear) of head.
Body aches starting at injection site and moving to whole body slightly after, lower back, hips starting at 1900. Chills for three hours starting day one at 2030. Sweating and headaches commencing after chills. Headache has gone down on day two, still massive body aches.
Prior to receiving my first dose of Moderna I was considered post menopausal and had not had a period in months. But a few weeks after my first Covid vaccine, I began to notice some irregular spotting and bleeding. I didn't put anything together until recently that it may be associated with my Covid vaccine. But it seems that after each vaccine, I've now had my fourth, the bleeding gets heavier. I had an ultrasound done, where they found a greater than 7 millimeter thickening of the uterine lining and have a uterine biopsy planned for the near future.
Headache, Malaise, Confusion, Blurred Vision, Nausea, Joint Pain, Dizziness, and TMJ flare ups. All symptoms have not subsided since the day after the 2nd vaccination shot. It has been 10-days.
Fever, cold, sinus infection, congestion,  strep throat, tonsillitis ear infection and I haven?t been sick even a cold in10 years.
This spontaneous case was reported by a patient and describes the occurrence of LIP SWELLING (severe lip swelling) and DENTAL DISCOMFORT (Dentist wont do dental work until it is resolved) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy (allergy to Penicillin), Allergic reaction to antibiotics (allergy to Cefalexin), Ragweed allergy and Osteoarthrosis (mild). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2022, the patient experienced LIP SWELLING (severe lip swelling). On an unknown date, the patient experienced DENTAL DISCOMFORT (Dentist wont do dental work until it is resolved). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, LIP SWELLING (severe lip swelling) and DENTAL DISCOMFORT (Dentist wont do dental work until it is resolved) outcome was unknown. She has had severe lip swelling after receiving the Moderna vaccine second shot and booster doses. She had not received Botox. She got a steroid shot after the second vaccination but it didn't help. She had lip swelling the last time she was allergic to a medication. It was reported that the dentist wont do dental work until it is resolved. This case was linked to MOD-2021-123424 (Patient Link).
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Nov2021 as dose 3 (booster), single (Lot number: Ew0185), in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 30Apr2022 as dose 4 (booster), single (Lot number: 001m21a), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: moderna (Dose 1, Lot number: 012a21a, vaccine location: left arm), administration date: 25Feb2021, for COVID-19 immunization; moderna (Dose 2, Lot number: 008b21-2a, vaccine location: left arm), administration date: 25Mar2021, for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: Blood cholesterol: High; SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient had no Known allergies. She received antiviral treatment with Paxlovid with Lot number GC9437 from 14Jul2022 indicated for COVID-19 treatment.
malaise; myalgias; This is a spontaneous report from a contactable physician (patient's parent). A 27-year-old male patient received second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patiently previously received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) at a single dose for COVID-19 immunization. The patient experienced malaise and myalgias which took place after the administration of second dose. He took Tylenol 6 hours ago, and the symptoms are decreasing. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Patient is a 33 year old female who has completed a 30-minute observation period with the following signs and symptoms of an adverse reaction: other - tingling sensation on left hand 10 mins p vaccination then tingling on both hands. Denies focal numbness/weakness, blurry vision, dizziness, cp, sob, angioedema. Denies anxiety. Vital signs stable. Physical exam unremarkable. Neuro intact. Tingling on hands improved. ED precautions given on focal weakness/numbness, sob, cp, angioedema. Sent home stable.
Patient was given undiluted Pfizer vaccine for age 5-11 years old. patient received 0.2 ml of undiluted vaccine, Patient was contacted the next day on 2/26/22 and parents reported that the child do not have any symptoms.
10 minutes after vaccine administration- patient started getting pruritic hives, diffuse redness, angioedema and respiratory distress.
Polyarthritis hands, feet about 4 wk after MMR. Has positive Rheumatoid Factor and positive anti-CCP. Synovitis in wrists 4 wks after onset.
This spontaneous report as received from a Registered Nurse via a company representative refers to a patient of unknown age. On 02-DEC-2013 the patient was vaccinated with an expired dose of ZOSTAVAX (lot # H012521, expiration date 09-OCT-2013, dose, route indications not reported). No symptoms reported. Additional information has been requested.
pt recv vax & devel fever, shivering, listless, closed eyes, drooping tongue;cont for 15min;exam @ 130PM-fever 39.6R otherwide NL tx:APAP PRN, observation;
As per mother's report, after patient was immunized, pt turned paled and felt weak, no LOC. Pt was brought to the treatment room and placed in the examining table in supine position. Pt recuperated completely about hr after. No treatment given.
light headed, dizzy, patient was evaluated and stated she was feeling better after laying down. patient laid down and waited her 15 min in the observation area. patient stated she felt fine after 15 min and went home
Injection site pain and swelling, Dizzy, Weak, Nausea/Throwing up, Fever, Chills, Headache, Rash all over torso.
Patient ended up feeling lightheaded and passed out for about 5 seconds and then came to and was given water.  Patient remained on site for 10 more minutes afterwards.  Patient stated they have felt this way before and get nervous around blood and needles and queasy.
This is a Spontaneous report from a contactable nurse based on the information received by Pfizer from Merck (Case ID: 00707005). A 70-years-old patient of an unspecified ethnicity and gender received PREVNAR 13, (Lot S74423 Exp 30Nov2019), via an unspecified route of administration in the left arm on 11Dec2017 at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced an injection site reaction in the left arm with "erythema 18 cm at the longest point." on an unspecified date with outcome of unknown. No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist via company representative refers to a male patient of unknown age. On an unknown date, the patient may has been vaccinated with ZOSTAVAX (dose, anatomical location, lot # and expiration date were not reported) by intramuscular route. On an unknown date, the patient experienced soreness at the site of ZOSTAVAX administration. The outcome of the event was unknown. The relatedness between the event and the vaccination with ZOSTAVAX was not provided. Additional information has been requested.
Patient has history of autoimmune inner ear disease. She has a left cochlear implant and noted hearing loss on right ear compared to her baseline approximately 1 week after first dose of covid vaccine.
Dizziness, Headache, Arthralgia, NauseaVomiting, disorientation, fatigue. Narrative:  ~12 hours after the shot and lasted from hour 12 to ~48 hours after the shot. Soreness in the ipsilateral arm. general body aches Headaches Fatigue Nausea/dizziness/lightheadedness/disorientation) lasted about 30 minutes, about 16 hours after the shot